| Literature DB >> 22189914 |
Wai-Man Tang1, Enoch Chan, Ching-Yee Kwok, Yee-Ki Lee, Jian-Hong Wu, Chun-Wai Wan, Robbie Yat-Kan Chan, Peter Hoi-Fu Yu, Shun-Wan Chan.
Abstract
The anticancer effects of traditional Chinese medicine (TCM) have attracted the attention of the public vis-à-vis existing cancer therapies with various side effects. Lycium barbarum fruit, commonly known as Gou Qi Zi in China, is a potential anticancer agent/adjuvant. Its major active ingredients, L. barbarum polysaccharides (LBP), scopoletin and 2-O-β-D-glucopyranosyl-L-ascorbic acid (AA-2βG), are found to have apoptotic and antiproliferative effects on cancer cell lines. Moreover, LBP also contributes to body's immunomodulatory effects and enhances effects of other cancer therapies. It is not known whether there are any undesirable effects. Further studies on its pharmacological mechanisms and toxicology could facilitate a safe usage of this TCM herb.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22189914 DOI: 10.1007/s10787-011-0107-3
Source DB: PubMed Journal: Inflammopharmacology ISSN: 0925-4692 Impact factor: 4.473